| MACULOPATHIE ET AUTRES ANOMALIES | |||||||||
| NON ANALYSABLE | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | TOTAL | |||
| OD | 20 | 70 | 0 | 7 | 3 | 2 | 102 | ||
| OG | 36 | 48 | 0 | 7 | 5 | 6 | 102 | ||
| OD + OG | 56 | 118 | 0 | 14 | 8 | 8 | 204 | ||
| N/A | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | ||||
| OD | 19,61% | 68,63% | 0,00% | 6,86% | 2,94% | 1,96% | 100,00% | ||
| OG | 35,29% | 47,06% | 0,00% | 6,86% | 4,90% | 5,88% | 100,00% | ||
| MOYENNE | 27,45% | 57,84% | 0,00% | 6,86% | 3,92% | 3,92% | 100,00% | ||
| NON ANALYSABLE | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | TOTAL | |||
| HOMMES | 5 | 40 | 0 | 2 | 4 | 2 | 53 | ||
| 9,43% | 75,47% | 0,00% | 3,77% | 7,55% | 3,77% | 100,00% | |||
| FEMMES | 11 | 25 | 0 | 6 | 2 | 5 | 49 | ||
| 22,45% | 51,02% | 0,00% | 12,24% | 4,08% | 10,20% | 100,00% | |||
| TOTAL | 16 | 65 | 0 | 8 | 6 | 7 | 102 | ||
| 15,69% | 63,73% | 0,00% | 7,84% | 5,88% | 6,86% | 100,00% | |||
|
|
|||||||||
|
|
|||||||||